Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
1 other identifier
interventional
28
1 country
1
Brief Summary
This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2016
CompletedFirst Submitted
Initial submission to the registry
July 12, 2016
CompletedFirst Posted
Study publicly available on registry
July 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 14, 2018
CompletedNovember 19, 2018
November 1, 2018
2.4 years
July 12, 2016
November 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
objective pill count
is greater or less than the amount of OAM that the patient should have in their possession.
1 year
Study Arms (2)
SMS/MMS text messaging
EXPERIMENTALPatients will be able to tailor their SMS/MMS reminders with respect to when (i.e., what time of day) they wish to receive the reminders, as well as how often the messages are sent (e.g., morning and evening).
usual care
ACTIVE COMPARATORThis includes physician and nursing assessment and intervention for any identified AEs. Of note, there is not currently standard follow-up that patients receive from nursing or physician staff while on an OAM treatment. Patients are encouraged to call their physician's office with any questions or changes in their medical status but are not called routinely by MSK staff.
Interventions
text messaging reminders on oral chemotherapy medication adherence
Eligibility Criteria
You may qualify if:
- Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
- Starting a new treatment regimen that includes a single oral anticancer medication
- Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
- Age 18 or older.
- Ability to speak and read English because we do not have the resources to translate the text messages into other languages.
You may not qualify if:
- Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Atkinson, PhD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2016
First Posted
July 14, 2016
Study Start
June 28, 2016
Primary Completion
November 14, 2018
Study Completion
November 14, 2018
Last Updated
November 19, 2018
Record last verified: 2018-11